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Introduction
Controlling MRSA has been a challenge for Geneva Uni-
versity Hospitals (HUG), particularly after the introduction
of ST228 SCCmecI hyperendemic clone in 1999.
Objectives
To describe HUG’s secular trends of MRSA, infection con-
trol measures and predominant MRSA clones using Staphy-
lococcal chromosomic cassettes (SCCmec) genotyping.
Methods
A multifaceted MRSA prevention program initiated in
1993 included patient screening, decontamination, surveil-
lance, contact isolation, an alert system and a hospital-
wide hand hygiene campaign (HHC); subsequently
strengthened by: an educational campaign (2003), routine
MRSA SCCmec genotyping (2005), a 2nd HHC, periodic
audits and feedback (2006). The intensive care unit per-
formed MRSA screening on admission, discharge and
weekly since 2004. Surveillance included: (1) incidence
rates (IR) of hospital acquired (HA)-MRSA infection or
colonization; (2) HA-MRSA bloodstream infections (BSI);
(3) proportion of MRSA/S. aureus BSI; (4) IR of MRSA
clinical cultures (CC); (5) proportion of SCCmec in MRSA
strains, assessed by routine multiplex PCR assay. Repre-
sentative isolates were grouped in MLVA clusters to eval-
uate genomic diversity and subjected to MLST.
Results
At HUG, from 2000-2014, 12,543 patients were MRSA-
colonized or infected (incl. >75% screening swabs; 530
BSI). From 2000-2007, annual rates of all indicators
showed an increasing trend, declining since 2008. New
HA-MRSA cases per 100 admissions increased from
1.36 to 2.00 (2006), and then declined to 0.29 (2014).
Trends expressed by incidence density of cases per 1000
hospital-days: HA-MRSA, from 0.92 to 1.36 (2007) to
0.21 (2014); ICU-acquired HA-MRSA from 2.3 (2002)
to 10.5 (2006) to 1.31 (2014); MRSA-CC rates from 0.68
to 1.44 (2008), to 0.24 (2014); HA-BSI from 0.049 to
0.07 (2009), to 0.016 (2014). The proportion of MRSA/
S. aureus BSI remained around 34% (2000-2009), declin-
ing to 18% (2014). SCCmecI strains declined from 83%
(2005) to 32% (2014); SCCmecII and SCCmecIV were
higher in non-acute settings.
Conclusion
A multifaceted prevention program and possible
changes in biologic fitness of the ST228 SCCmecI clone
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